Peer Review History

Original SubmissionNovember 29, 2025
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Decision Letter - Tope Ipinnimo, Editor

PONE-D-25-63289Evaluating conflict-of-interest governance among Canadian medical societies using a novel assessment tool: a cross-sectional studyPLOS One

Dear Dr. Lexchin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 29 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tope Michael Ipinnimo, MBBS, MPH, FWACP, FMCPH

Academic Editor

PLOS One

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments:

Kindly address the comments of the reviewers.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is well written and organized, and the data availability and reporting standards meet PLOS ONE requirements. I have no major concerns except from some minor issues; Typo/wording: “Policy presense” in the Results section should be “Policy presence.”

- Consistency and clarity: Consider defining early what counts as a “policy item” vs. a “domain,” then keep the wording consistent throughout.

Reviewer #2: The manuscript presents a novel, systematic evaluation of conflict-of-interest (COI) policies among Canadian medical societies. The topic is of high relevance to medical ethics, professional self-regulation, and public trust. The study is well-written, well-structured, the methodology is clearly described, and the findings are stark and impactful, clearly demonstrating a major gap in transparent COI governance. However, several major methodological and interpretive issues need to be addressed to strengthen the validity of the conclusions and the utility of the tool, these include:

-) MAJOR COMMENTS:

1. The core of this study is the novel 51-item tool. While the expert review process is noted, the manuscript does not thoroughly address the tool's construct validity in terms of system scoring, Item and Domain Selection, and weighing.

2. It is crucial to have a robust justification for the decision and its ramifications, as limiting the search to public websites represents a major methodological choice.

3. Tables 3, 4, and 6 are dense and somewhat confusing. Table 3's "Depth of coverage" columns are hard to parse. Consider simplifying. For Table 6, the "% of Max" column is useful but requires careful reading. Ensure the caption/footnote clearly explains that a lower percentage indicates a more restrictive overall policy stance.

4. The low "depth" scores are highlighted. This could be interpreted not only as a policy weakness but also that the tool is very comprehensive. This dual interpretation should be acknowledged.

5. The discussion suggests policies are "reactive" and "compliance-driven." While plausible, this is still a speculative from a cross-sectional study. It is thus strongly suggested to refine informal phrasing (such as “implying” or “indicating”) to underscore the relational elements within your observations.

-----------

-) MINOR COMMENTS:

1. In the abstract, the authors wrote "Systematically searched their websites".

Could be slightly more specific (e.g., "publicly accessible sections of their websites").

2. Line 38: Typo: "a 38 nd staff COI" -> "and staff COI".

3. Line 288: "The analysis of the policies does not apply to policies of excluded Canadian organizations..." This sentence is awkward. Rephrase for clarity.

3. In Discussion section (Subtle: International Comparison): The comparison with the Australian study (Kerridge et al. 2005) is excellent as it contrasts your finding on speaker declarations. Emphasize this point of difference more. .

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ayokunle Oluwadoyinsola Adedipe

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Revision 1

Reviewer #1:

Reviewer #1 comments

The manuscript is well written and organized, and the data availability and reporting standards meet PLOS ONE requirements. I have no major concerns except from some minor issues

Authors’ response

Thank you for your positive feedback upon your reading of our manuscript.

Reviewer #1 comments

Typo/wording: “Policy presense” in the Results section should be “Policy presence.”

Authors’ response

Thank you for spotting this typo, we have now corrected the spelling.

Reviewer #1 comments

Consistency and clarity: Consider defining early what counts as a “policy item” vs. a “domain,” then keep the wording consistent throughout.

Authors’ response

Thank you for flagging that this distinction was not made clear from the outset. We have now revised the paragraph in the methods section under ‘Tool to analyze policies’ to clarify how these terms are interpreted. Specifically, we now say “The resulting tool consisted of discrete policy items (i.e. specific policy provisions or rules) grouped into broader thematic domains (i.e. categories of related policy items addressing a common policy area.”

Reviewer #2 comments

The manuscript presents a novel, systematic evaluation of conflict-of-interest (COI) policies among Canadian medical societies. The topic is of high relevance to medical ethics, professional self-regulation, and public trust. The study is well-written, well-structured, the methodology is clearly described, and the findings are stark and impactful, clearly demonstrating a major gap in transparent COI governance. However, several major methodological and interpretive issues need to be addressed to strengthen the validity of the conclusions and the utility of the tool, these include

Authors’ response

We are very grateful for your time in engaging with our manuscript. We have enjoyed engaging with your suggestions and feel the manuscript has been strengthened as a result.

Reviewer #2 comments

Major comments

1. The core of this study is the novel 51-item tool. While the expert review process is noted, the manuscript does not thoroughly address the tool's construct validity in terms of system scoring, Item and Domain Selection, and weighing.

Authors’ response

Thank you for your suggestion to expand our discussion around the tool’s construct validity. In response, we have expanded the Methods section to clarify the conceptual and methodological foundations of the assessment tool, in particular please see the revised “Tool to analyze policies” subsection.

Specifically, we now describe (1) the literature-informed process used to identify and synthesise policy items from prior institutional COI governance frameworks; (2) the rationale for domain structure based on areas where conflicts of interest have been shown to influence medical society activities – for each domain we now include a reference; (3) the iterative expert review process involving 10 researchers with extensive experience in COI policy development and analysis; and (4) the rationale for the scoring system and equal weighting of items to ensure transparency and avoid subjective prioritisation. We also note that this development approach is consistent with established methods used in prior institutional COI policy assessment tools, specifically in academic medical centres.

Reviewer #2 comments

2. It is crucial to have a robust justification for the decision and its ramifications, as limiting the search to public websites represents a major methodological choice.

Authors’ response

We thank you for highlighting the need to more clearly justify this methodological decision. We have revised the Methods section to clarify that restricting the search to publicly accessible policies was intentional and to explain the implications of this choice. The revised text now states: “Policies were identified through a systematic search of publicly accessible sections of each society’s website.” We further clarify the rationale for this approach: “We focused on publicly available policies because these represent the standards communicated to external stakeholders and therefore constitute the most transparent and publicly accountable form of organizational governance.”

We also explain the implications for reproducibility and data collection, noting that “Restricting the search to publicly accessible materials also ensured methodological reproducibility, as access to password-protected or internal documents varies across organizations and investigators.” Finally, we clarify that societies were not contacted and specify the scope of the analysis: “We did not contact medical societies to request additional policies because our objective was to evaluate policies accessible to any interested party. Consequently, our analysis reflects the policies that societies make publicly available rather than any internal policies that may exist.”

Reviewer #2 comments

3. Tables 3, 4, and 6 are dense and somewhat confusing. Table 3's "Depth of coverage" columns are hard to parse. Consider simplifying. For Table 6, the "% of Max" column is useful but requires careful reading. Ensure the caption/footnote clearly explains that a lower percentage indicates a more restrictive overall policy stance.

Authors’ response

Thank you for your reflections on the Tables, this is very helpful and we have made some amendments as a result.

To address the confusing presentation of Table 3 (now Table 4), we have divided it into two separate tables. Previously, it was combining breadth and depth which we agree made it confusing for the reader. Splitting the Table into two also has the added benefit of better aligning with the text, as we have a section for breadth and a section for depth.

We have added an additional sentence to the footnote for Table 6 (now Table 7) to clarify how readers can interpret the scores – “*Percentage of maximum represents the absolute score as a percentage of the maximum (most permissive) possible score if all items were scored as 2. Lower percentages indicate more restrictive overall policy positions, whereas higher percentages indicate more permissive policies.”

Reviewer #2 comments

4. The low "depth" scores are highlighted. This could be interpreted not only as a policy weakness but also that the tool is very comprehensive. This dual interpretation should be acknowledged.

Authors’ response

We appreciate this point and have inserted an additional sentence to reflect the dual interpretation, as you suggested. We now state: “Even within policies, depth of coverage was modest: on average, societies addressed fewer than one-third of the relevant items within each domain. While this could be interpreted as a policy weakness, it may also reflect the comprehensiveness of our tool.”

Reviewer #2 comments

5. The discussion suggests policies are "reactive" and "compliance-driven." While plausible, this is still a speculative from a cross-sectional study. It is thus strongly suggested to refine informal phrasing (such as “implying” or “indicating”) to underscore the relational elements within your observations.

Authors’ response

Thank you for highlighting this. We appreciate and agree there is a need to avoid speculative interpretations and causal language as this is not supported by our research design.

We have revised with discussion section to use more cautious, relational phrasing that emphasises observed policy characteristics rather than institutional intent or motivations. Specifically:

- We replaced stronger interpretative language with observational phrases (e.g. "more frequently observed”, “more frequently included”, “consistent with”, “may suggest”, and “may have implications”).

- We reframed statements about policy orientation to focus on structural patterns (e.g. “consistent with COI governance being structured around meeting external requirements”) rather than implying institutional motives

- We clarified interpretative statements by introducing hedging language (e.g. “may”, “suggest”, “comparatively”).

- We revised statements about potential impacts to emphasise implications rather than direct causal effects.

We retained one instance of the term “reactive”, but softened the phrasing to: “This pattern may suggest a comparatively reactive rather than proactive approach,” which we believe conveys a cautious interpretation of observed policy features rather than a claim about organisational intent.”

We feel these revisions ensure that our discussion remains proportionate to the study design while preserving the policy-relevant insights of our findings.

Reviewer #2 comments

Minor comments

1. In the abstract, the authors wrote "Systematically searched their websites".

Could be slightly more specific (e.g., "publicly accessible sections of their websites").

Authors’ response

Thank you for this helpful suggestion. We have clarified the scope of our search by revising the sentence to specify that only publicly accessible website content was reviewed. The sentence now reads: “We identified 68 Canadian medical societies meeting our inclusion criteria and systematically searched the publicly accessible sections of their websites for COI policies.”

Reviewer #2 comments

2. Line 38: Typo: "a 38 nd staff COI" -> "and staff COI".

Authors’ response

Thank you for pointing this out. This typo did not appear on our original Word copy, but may have occurred during the submission process. We have ensured that it does not appear in the revised version.

Reviewer #2 comments

3. Line 288: "The analysis of the policies does not apply to policies of excluded Canadian organizations..." This sentence is awkward. Rephrase for clarity.

Authors’ response

Thank you for pointing this out to us. We have now rephrased this sentence so it reads: “Our findings do not extend to organizations excluded under our eligibility criteria (e.g. regulatory colleges, accrediting bodies, broad physician associations, or multidisciplinary organizations) or to medical societies in other countries.”

Reviewer #2 comments

4. In Discussion section (Subtle: International Comparison): The comparison with the Australian study (Kerridge et al. 2005) is excellent as it contrasts your finding on speaker declarations. Emphasize this point of difference more.

Authors’ response

Thank you for identifying this as an important point of contrast between our findings and other contexts. We have sharpened the phrasing to draw more attention to this fact by adding an additional sentence:

“In Australia, Kerridge et al. (19) reported that 20 of 29 responding organizations (from 63 contacted) had policies or guidelines governing industry relationships. However, these policies appeared limited in scope: 62% of organizations did not require speakers to declare COIs at educational meetings. This contrasts with our findings, where speaker declaration requirements was the most frequently addressed policy item across all items in our study. The increase in the percent of policies requiring speaker disclosure may reflect an expanding recognition of the influence of COI”

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Tope Ipinnimo, Editor

Evaluating conflict-of-interest governance among Canadian medical societies using a novel assessment tool: a cross-sectional study

PONE-D-25-63289R1

Dear Dr. Joel Lexchin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tope Michael Ipinnimo, MBBS, MPH, FWACP, FMCPH

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have adequately addressed the concerns raised in the previous round of review. One grammatical error was introduced in the newly added text in the Discussion section (International Comparison): "speaker declaration requirements was the most frequently addressed policy item" - "requirements" is plural and should read "were" instead of "was." This should be corrected prior to publication.

Reviewer #2: All issues of concern have been meticulously addressed. The manuscript is now methodologically rigorous, clearly presented.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Tope Ipinnimo, Editor

PONE-D-25-63289R1

PLOS One

Dear Dr. Lexchin,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tope Michael Ipinnimo

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .